We describe a versatile and tuneable thiol responsive linker system using thiovinylketones, that relies on the conjugate addition–elimination mechanism of Michael acceptors for the traceless release of therapeutics.
Herein, we report a semi-synthetic strategy for generating Fc–peptide conjugates via disulfide re-bridging linker bioconjugation that retained biological activity in vitro and exhibited prolonged circulation in vivo .